Pharmacognostical, Pharmaceutical and Analytical Standardization of Shirishadi Arka through Physicochemical Evaluation, HPTLC Profiling, GC MS Characterization and Safety Assessment.
DOI:
https://doi.org/10.70066/jahm.v14i6.2883Keywords:
Analytical Study, COPD, GC-MS, HPTLC, Pharmacognostical Study, Pharmaceutical Study, Shirishadi Arka, Tamaka ShwasaAbstract
Background: Standardization of Ayurvedic formulations is essential to ensure their safety, quality, and reproducibility. Shirishadi Arka is an Anubhuta Yoga traditionally indicated in respiratory disorders such as Shwasa and Kasa. Aim: To prepare Shirishadi Arka and establish its pharmacognostical, pharmaceutical, and analytical standardization using modern scientific parameters. Objectives: To understand the preparation of Shirishadi Arka by method of distillation. To determine the analytical tests like physico-chemical parameters, and tests for heavy metals to assure to evaluate the pharmaceutical and analytical standardization. Gas chromatography-mass spectrometry analysis to investigate potential properties of Shirishadi Arka. Material and Methods: The formulation was prepared by classical distillation (Arka Kalpana) using Shirisha (Albizia lebbeck), Musta (Cyperus rotundus), and Kantakari (Solanum xanthocarpum). Pharmacognostical evaluation was carried out for authentication of raw drugs. Physicochemical parameters, microbial load, heavy metal analysis, pesticide residue were performed as per API guidelines. High Profile Thin Layer Chromatography (HPTLC) was employed for preliminary fingerprinting, while Gas Chromatography–Mass Spectrometry (GC–MS) analysis was conducted for phytochemical profiling. All experiments were performed in triplicate (n = 3), and results were expressed as mean ± standard deviation. Analytical methods were validated for precision and repeatability. Results: The formulation complied with API standards. Physicochemical parameters showed pH 7.00 ± 0.05, specific gravity 1.0033 ± 0.002, and total solid content 0.052 ± 0.003 % w/v. Microbial, heavy metal and pesticide residue analysis were within permissible limits. HPTLC analysis demonstrated distinct chromatographic patterns. GC–MS analysis identified 50 phytoconstituents, including fatty acids, terpenoids, and phytosterols such as n-hexadecanoic acid, γ-tocopherol, and β-sitosterol derivatives. %RSD values were within acceptable limits, indicating good reproducibility. Conclusion: The study establishes a comprehensive standardization profile of Shirishadi Arka. The presence of bioactive compounds with known anti-inflammatory and antioxidant properties supports its traditional use in respiratory disorders such as COPD (Tamaka Shwasa).
References
GOLD Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2021 Repost. Global Initiative for Chronic Obstructive Lung Disease—GOLD. 2021. Available online: https://goldcopd.org/2021-gold-reports/
Wang Y, Xu J, Meng Y, Adcock IM, Yao X. Role of inflammatory cells in airway remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3341–3348. doi: https://doi.org/10.2147/COPD.S176122
McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Paré PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011 Oct 27;365(17):1567–75. doi: https://doi.org/10.1056/NEJMoa1106955
Ravana. Arkaprakasha. Tripathi I, editor and commentator, 2nd edition, Varanasi: Chaukhambha Sanskrit Series Office; 2006; Prathama Shataka;8–9
The Ayurvedic Pharmacopoeia of India. Part II, Vol. III. 1st ed. New Delhi: Ministry of Health and Family Welfare, Government of India; 2007;1
Divya Kajaria, Jyotishankar Tripathi, Shrikant Tiwari. Anti-asthmatic effect of Shirishadi compound through nasal spray actuation. AYU 2014; 35 (3): 261-269. Available from DOI: https://doi.org/10.4103/0974-8520.153738
Acharya YT, editor, Sushruta Samhita with Nibandhasangraha Commentary of Dalhanacharya, Kalpasthana, Annapanaraksha Kalpa, Chapter 1, Verse no. 25–26. Varanasi: Chaukambha Surabharati Prakashana; 2014;566
Sharma PV. Dravyaguna Vijnana. Vol. 2, Reprint ed, Varanasi: Chaukhambha Bharati Academy; 2015;370–372
Kamat SD, editor. Bhavaprakasha Nighantu (Vol. 1) with Vaishali English commentary. Guduchyadi Varga, verse no. 41–42, 1st edition. Delhi: Chaukhamba Sanskrit Pratishthan; 2018;387
The Ayurvedic Pharmacopeia of India, Pharmacopeia commission for Indian Medicine& Homeopathy; Edition-III, Part-1, Volume-IV;2007;87
The Ayurvedic Pharmacopoeia of India, Govt. of India: Ministry of Health and Family Welfare; Edition-I, Part II, Vol. I;2007;191
The Ayurvedic Pharmacopoeia of India, Govt. of India: Ministry of Health and Family Welfare; Edition-I, Part II, Vol. I;2007;190
The Ayurvedic Pharmacopoeia of India, Govt. of India: Ministry of Health and Family Welfare; Edition-I, Part II, Vol. I;2007;199
Khandelwal K. R, Editor. Practical Pharmacognosy: Techniques and Experiments, 19th ed, Nirali Prakashan, Pune; 2007;151-153
Kowalska T, Sajewicz M. Thin-layer chromatography (TLC) in the screening of botanicals– its versatile potential and selected applications. Molecules. 2022; 27(19):6607. Available from doi: https://www.mdpi.com/1420-3049/27/19/6607.
The Ayurvedic Pharmacopoeia of India, Govt. of India: Ministry of Health and Family Welfare; Edition-I, Part II, Vol. I;2007;144
The Ayurvedic Pharmacopoeia of India, Govt. of India: Ministry of Health and Family Welfare; Edition-I, Part II, Vol. I;2007;186
M A I, Ramalingam K, Shanmugam R. Biomedical applications of lauric acid: a narrative review. Cureus. 2024 Jun 20;16(6):e62770. doi: https://doi.org/10.7759/cureus.62770
The role of Myristic acid in the pathogenesis of pulmonary fibrosis European Respiratory Journal 2025 66(suppl 69): PA1062; Available from DOI: https://doi.org/10.1183/13993003.congress-2025.PA1062
Aparna V, Dileep KV, Mandal PK, Karthe P, Sadasivan C, Haridas M. Anti-inflammatory property of n-hexadecanoic acid: structural evidence and kinetic assessment. Chem Biol Drug Des. 2012;80(3):434–9. doi: https://doi.org/10.1111/j.1747-0285.2012.01418.
Romero-Martínez N, Ramos-Zambrano E, Osorio-Ruiz A, Martínez-Ayala AL. Main Mechanisms of Action of Policosanol in Animal and Plant Cells. Int J Pharm Res Allied Sci. 2021;10(2):10-20. Available from DOI: https://doi.org/10.51847/fGCmHjlN8k
Yazdani, R., Fallah, H., Yazdani, S. et al. Effect of plasma free fatty acids on lung function in male COPD patients. Sci Rep 15, 3377 (2025). Avaialble from DOI https://doi.org/10.1038/s41598-025-86628-1
Revol-Cavalier J, Quaranta A, Newman JW, Brash AR, Hamberg M, Wheelock CE. The octadecanoids: synthesis and bioactivity of 18-carbon oxygenated fatty acids in mammals, bacteria, and fungi. Chem Rev. 2025;125(1):1–90. doi: https://doi.org/10.1021/acs.chemrev.3c00520
Analysis_of_bioactive_chemical_compounds_of_Nigella_sativa_using_gas_chromatography-mass_spectrometry Available from DOI: https://www.researchgate.net/publication/298715438_
Bin Sayeed MS, Karim SMR, Sharmin T, Morshed MM. Critical analysis on characterization, systemic effect, and therapeutic potential of beta-sitosterol: a plant-derived orphan phytosterol. Medicines (Basel). 2016 Nov 15;3(4):29. doi: https://doi.org/10.3390/medicines3040029
Stigmasterol_in_Health_and_Disease_A_Review Available from: https://www.researchgate.net/publication/362643996_
Munukuntla R, Tiwari A, Yadav RS, et al. Microbiological acceptance criteria, specifications of herbal drugs and herbal drug preparations in various pharmacopoeias: a global scenario. DARU Journal of Pharmaceutical Sciences. 2024;32:461–468. Available from: https://doi.org/10.1007/s40199-024-00510-5
Sharma V, Gupta R, Lee J-H, et al. Determination of catechins and catechin gallates in biological fluids by HPLC with coulometric array detection and solid phase extraction. Anal Chim Acta. 2004;510(1):69–76. Available from: https://doi.org/10.1016/j.aca.2003.12.060.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Kshitiz Koundal, Hetal D Vyas, Mandip Goyal, Arjun Mukeshbhai Pandya

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.